Novel therapeutics for the treatment of metastatic melanoma

Author： Mansfield Aaron S Markovic Svetomir N

ISSN： 1479-6694

Source： Future Oncology, Vol.5, Iss.4, 2009-05, pp. : 543-557

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oblimersen in the treatment of metastatic melanoma

By Tarhini Ahmad A Kirkwood John M

Future Oncology, Vol. 3, Iss. 3, 2007-06 ,pp. : 263-271

Future Medicine

Access to resources Recommend Favorite

Treatment of metastatic malignant melanoma with dacarbazine plus fotemustine

By Seeber A. Binder M. Steiner A. Wolff K. Pehamberger H.

European Journal of Cancer, Vol. 34, Iss. 13, 1998-12 ,pp. : 2129-2131

Elsevier

Access to resources Recommend Favorite

Current and Future Directions in the Treatment of Metastatic Malignant Melanoma

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 3, Iss. 6, 2003-11 ,pp. : 393-398

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Molecular-Targeted Therapeutics for the Treatment of Cancer

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 8, Iss. 5, 2008-06 ,pp. : 470-480

Bentham Science Publishers

Access to resources Recommend Favorite

ASCO 2013—treatment of metastatic melanoma: is it still a story of success?

By Weinlich Georg

memo - Magazine of European Medical Oncology, Vol. 6, Iss. 4, 2013-12 ,pp. : 244-246

Springer Publishing Company

Access to resources Recommend Favorite